These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity. Heuer H Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739 [No Abstract] [Full Text] [Related]
45. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats. Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350 [TBL] [Abstract][Full Text] [Related]
46. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125 [TBL] [Abstract][Full Text] [Related]
47. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. Schwinger RH; Böhm M; La Rosée K; Erdmann E Am Heart J; 1992 Aug; 124(2):320-30. PubMed ID: 1322030 [TBL] [Abstract][Full Text] [Related]
48. Involvement of platelet-activating factor (PAF) in endotoxin- or ischaemia-induced intestinal hyperpermeability in the rat. Defaux JP; Thonier F; Baroggi N; Etienne A; Braquet P J Lipid Mediat; 1993 May; 7(1):11-21. PubMed ID: 8358021 [TBL] [Abstract][Full Text] [Related]
49. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. Brecht HM; Adamus WS; Heuer HO; Birke FW; Kempe ER Arzneimittelforschung; 1991 Jan; 41(1):51-9. PubMed ID: 1646613 [TBL] [Abstract][Full Text] [Related]
51. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372 [TBL] [Abstract][Full Text] [Related]
52. Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets. de Boissieu D; Canarelli JP; Cordonnier C; Richard S; Léké A; Tarrade T; Postel JP; Dupont C J Pediatr Surg; 1996 Dec; 31(12):1675-9. PubMed ID: 8986985 [TBL] [Abstract][Full Text] [Related]
54. Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. Will PC; Thomas TK; Iverson L; Buckman D; Weis W; Wilson C; Srivastava A Agents Actions; 1991 Sep; 34(1-2):181-4. PubMed ID: 1793026 [TBL] [Abstract][Full Text] [Related]
55. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity. Bouvier C; Guc MO; Furman BL; Parratt JR Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505 [TBL] [Abstract][Full Text] [Related]
56. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine]. Kulikov VI; Muzia GI Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455 [TBL] [Abstract][Full Text] [Related]
57. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Toth PD; Mikulaschek AW Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423 [TBL] [Abstract][Full Text] [Related]
58. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
59. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. Chang SW; Ohara N; Kuo G; Voelkel NF Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951 [TBL] [Abstract][Full Text] [Related]
60. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. Hill ME; Bird IN; Daniels RH; Elmore MA; Finnen MJ J Immunol; 1994 Oct; 153(8):3673-83. PubMed ID: 7930587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]